AI assistant
Sending…
MUSTANG BIO, INC. — Director's Dealing 2021
Jul 8, 2021
35167_dirs_2021-07-08_b63c047a-682e-4edc-b47a-918f95b72535.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2021-06-28
Reporting Person: ROSENWALD LINDSAY A MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-28 | COMMON STOCK | A | 13774 | $0.00 | Acquired | 217253 | Direct |
Footnotes
F1: The Reporting Person was granted 13,774 restricted shares pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date.
F2: Includes restricted share units, which vest over various time periods.
More from MUSTANG BIO, INC.
Interim / Quarterly Report
2026
May 5
Delisting Announcement
2026
Apr 17
Major Shareholding Notification
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Proxy Solicitation & Information Statement
2025
Dec 3
Interim / Quarterly Report
2025
Nov 7